NEWS

Tampa, Fla. & Cazenovia, N.Y. October 22, 2024 – Meaningful Insights Biotech Analytics, LLC (MiBA) and the National Community Oncology Dispensing Association (NCODA) are pleased to announce their partnership on the launch of the Oncology Insights Program (OIP), an innovative and educational initiative powered by prescriber data. This collaboration aims to provide healthcare professionals (HCPs) […]

CAZENOVIA, NY, August 15, 2024  – NCODA is excited to announce the addition of five highly esteemed professionals to its Executive Council: Natalie Dickson, MD, Ken Komorny, PharmD, BCPS, Kim Le, PharmD, Wafa Samara, PharmD, and Nathan Shumway, DO, FACP. These new appointees bring a wealth of experience and dedication to the oncology field, reinforcing […]

WASHINGTON, D.C. – Reps. Earl L. “Buddy” Carter (R-GA), Nanette Barragán (D-CA), and Mariannette Miller-Meeks (R-IA) today celebrated the Biden administration’s decision to drop its appeal in a case against the patient community, keeping in effect the District of Columbia’s District Court ruling affirming the 2020 Notice of Benefit and Payment Parameters (NBPP) Final Rule requiring that […]

– Approval based on positive data from Phase 3 DeFi trial, in which OGSIVEO significantly improved progression-free survival and objective response rate, with rapid and sustained improvements in pain, physical functioning and overall quality of life – STAMFORD, Conn., Nov. 27, 2023 (GLOBE NEWSWIRE) — SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on […]

– Integrated cancer care professionals to address treatments, shortages, and operational advances driving improved outcomes –   Orlando, FL – October 23, 2023 – Physicians, nurses, pharmacists, and other important clinical and administrative team members, along with partnering pharmaceutical industry representatives from all over the world will gather in Orlando October 25-27 for the NCODA […]

Desmoid tumors are rare, locally aggressive soft tissue tumors1 Until October 1, 2023, desmoid tumors fell under an ICD-10-CM code (D48.1) covering a variety of connective and soft tissue tumors of “uncertain behavior”2 As of October 1, 2023, ICD-10-CM diagnosis codes are available for desmoid tumors2   On October 1, 2023, location-specific International Classification of […]

JUNE 13, 2023 The PAN Foundation today announced opposition to alternative funding programs, which jeopardize patient access to specialty medications and redirect finite charitable funds away from uninsured and underinsured patients. We urge Congress and the administration to learn about the growing use of alternative funding programs, understand their detrimental impact on patients, and evaluate options […]

May 22, 2023 at 4:04 PM EDT — For the first time, patients with indolent SM have a medicine that treats the primary disease driver and is proven to provide broad and durable symptom relief — — Approval based on the positive PIONEER trial, in which once-daily AYVAKIT achieved significant improvements in disease symptoms and […]

[CAZENOVIA, NY – April 27, 2023] – NCODA urges the Centers for Medicare & Medicaid Services (CMS) to immediately retract a portion of a Frequently Asked Questions (FAQ) that suggests that physician practices mailing medications would violate the federal prohibition on self-referral for ancillary services (Stark law). At present, the Public Health Emergency (PHE) that […]

[CAZENOVIA, NY – March 30, 2023] – NCODA University, a division of NCODA that provides top-tier education for future and present oncology pharmacists, has launched a new 15-hour Oncology Basics Course. This first-of-its-kind course will reinforce knowledge of the etiology and pathophysiology of cancer, provide a deeper understanding of commonly used anti-cancer drug classes, and […]